Predominance of carbapenem-resistant pseudomonas aeruginosa isolates carrying blaIMP and blaVIM metallo-β-lactamases in a major hospital in Costa Rica

Journal of Medical Microbiology

Volumn 64, Issue 1, 2015, Pages 37-43

  Toval, Francisco ^a,c   Guzmán Marte, Anel ^a,d   Madriz, Vivian ^a,e   Somogyi, Teresita ^a,b   Rodríguez, César ^a   García, Fernando ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b Hospital Mexico   (Costa Rica)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d Hospital General de la Plaza de la Salud   (Dominican Republic)

^e Boston Scientific ^*  (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; METALLO BETA LACTAMASE GIM1; METALLO BETA LACTAMASE IMP; METALLO BETA LACTAMASE VIM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIMENTIN; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL DNA; BETA LACTAMASE; CARBAPENEM DERIVATIVE; QUINOLONE DERIVATIVE;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CARBAPENEM RESISTANT PSEUDOMONAS AERUGINOSA; CONTROLLED STUDY; COSTA RICA; EMERGENCY WARD; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENE CASSETTE; GENE FUNCTION; GENETIC VARIABILITY; HOSPITAL; INTEGRON; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; CLUSTER ANALYSIS; DRUG EFFECTS; ENZYMOLOGY; EPIDEMIOLOGY; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR TYPING; PSEUDOMONAS INFECTION; RANDOM AMPLIFIED POLYMORPHIC DNA; SECRETION (PROCESS); TERTIARY CARE CENTER;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CLUSTER ANALYSIS; COSTA RICA; DNA, BACTERIAL; FLUOROQUINOLONES; GENOTYPE; HUMANS; MOLECULAR TYPING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TERTIARY CARE CENTERS;

EID: 84919742698     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.081802-0     Document Type: Article

References (43)

1. Andrade, S. S., Jones, R. N., Gales, A. C. & Sader, H. S. (2003). Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001). J Antimicrob Chemother 52, 140-141.
2. Bebrone, C., Bogaerts, P., Delbrück, H., Bennink, S., Kupper, M. B., Rezende de Castro, R., Glupczynski, Y. & Hoffmann, K. M. (2013). GES-18, a new carbapenem-hydrolyzing GES-Type β-lactamase from Pseudomonas aeruginosa that contains Ile80 and Ser170 residues. Antimicrob Agents Chemother 57, 396-401.
3. Borgianni, L., Prandi, S., Salden, L., Santella, G., Hanson, N. D., Rossolini, G. M. & Docquier, J.-D. (2011). Genetic context and biochemical characterization of the IMP-18 metallo-β-lactamase identified in a Pseudomonas aeruginosa isolate from the United States. Antimicrob Agents Chemother 55, 140-145.
4. Breidenstein, E. B. M., de la Fuente-Núñez, C. & Hancock, R. E. W. (2011). Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol 19, 419-426.
5. Castillo-Vera, J., Ribas-Aparicio, R. M., Nicolau, C. J., Oliver, A., Osorio-Carranza, L. & Aparicio-Ozores, G. (2012). Unusual diversity of acquired β-lactamases in multidrug-resistant Pseudomonas aeruginosa isolates in a Mexican hospital. Microb Drug Resist 18, 471-478.
6. Cornaglia, G., Giamarellou, H. & Rossolini, G. M. (2011). Metallo-blactamases: a last frontier for β-lactams? Lancet Infect Dis 11, 381-393.
7. Dwivedi, M., Mishra, A., Azim, A., Singh, R. K., Baronia, A. K., Prasad, K. N., Dhole, T. N. & Dwivedi, U. N. (2009). Ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae carrying multiple metallo-β-lactamase genes. Indian J Pathol Microbiol 52, 339-342.
8. El Garch, F., Bogaerts, P., Bebrone, C., Galleni, M. & Glupczynski, Y. (2011). OXA-198, an acquired carbapenem-hydrolyzing class D blactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 55, 4828-4833.
9. Foca, M. D. (2002). Pseudomonas aeruginosa infections in the neonatal intensive care unit. Semin Perinatol 26, 332-339.
10. Garau, J. & Gomez, L. (2003). Pseudomonas aeruginosa pneumonia. Curr Opin Infect Dis 16, 135-143.
11. Garza-Ramos, U., Tinoco, P., Silva-Sanchez, J., Morfin-Otero, R., Rodriguez-Noriega, E., Leon-Garnica, G., Sader, H. S. & Jones, R. N. (2008). Metallo-β-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico. Int J Antimicrob Agents 31, 78-80.
12. Hanson, N. D., Hossain, A., Buck, L., Moland, E. S. & Thomson, K. S. (2006). First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-β-lactamase, IMP-18. Antimicrob Agents Chemother 50, 2272-2273.
13. Hocquet, D., Plésiat, P., Dehecq, B., Mariotte, P., Talon, D., Bertrand, X. & ONERBA (2010). Nationwide investigation of extendedspectrum β-lactamases, metallo-β-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France. Antimicrob Agents Chemother 54, 3512-3515.
14. Klockgether, J., Cramer, N., Wiehlmann, L., Davenport, C. F. & Tümmler, B. (2011). Pseudomonas aeruginosa genomic structure and diversity. Front Microbiol 2, 150.
15. Lambert, P. A. (2002). Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J R Soc Med 95 (Suppl 41), 22-26.
16. Lee, M. F., Peng, C. F., Hsu, H. J. & Chen, Y. H. (2008). Molecular characterisation of the metallo-β-lactamase genes in imipenemresistant Gram-negative bacteria from a university hospital in southern Taiwan. Int J Antimicrob Agents 32, 475-480.
17. Lee, K., Kim, C. K., Hong, S. G., Choi, J., Song, S., Koh, E., Yong, D., Jeong, S. H., Yum, J. H. & other authors (2010). Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-β-lactamases. Int J Antimicrob Agents 36, 259-263.
18. Lévesque, C., Piché, L., Larose, C. & Roy, P. H. (1995). PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 39, 185-191.
19. Lister, P. D., Wolter, D. J. & Hanson, N. D. (2009). Antibacterialresistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22, 582-610.
20. Martinez, E., Marquez, C., Ingold, A., Merlino, J., Djordjevic, S. P., Stokes, H. W. & Chowdhury, P. R. (2012). Diverse mobilized class 1 integrons are common in the chromosomes of pathogenic Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 56, 2169-2172.
21. Maschmeyer, G. & Braveny, I. (2000). Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis 19, 915-925.
22. Master, R. N., Clark, R. B., Karlowsky, J. A., Ramirez, J. & Bordon, J. M. (2011). Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009. Int J Antimicrob Agents 38, 291-295.
23. Mendes, R. E., Kiyota, K. A., Monteiro, J., Castanheira, M., Andrade, S. S., Gales, A. C., Pignatari, A. C. C. & Tufik, S. (2007). Rapid detection and identification of metallo-β-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J Clin Microbiol 45, 544-547.
24. Morrison, A. J., Jr & Wenzel, R. P. (1984). Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 6 (Suppl 3), S627-S642.
25. Nicolau, C. J. & Oliver, A. (2010). Carbapenemases in Pseudomonas spp. Enferm Infecc Microbiol Clin 28 (Suppl 1), 19-28.
26. Pallecchi, L., Riccio, M. L., Docquier, J. D., Fontana, R. & Rossolini, G. M. (2001). Molecular heterogeneity of bla(VIM-2)-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-β-lactamase. FEMS Microbiol Lett 195, 145-150.
27. Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S., Cavallo, J. D. & Nordmann, P. (2000). Characterization of VIM-2, a carbapenemhydrolyzing metallo-β-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 44, 891-897.
28. Poirel, L., Lambert, T., Türkoglü, S., Ronco, E., Gaillard, J. L. & Nordmann, P. (2001). Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenemhydrolyzing β-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob Agents Chemother 45, 546-552.
29. Pollini, S., Maradei, S., Pecile, P., Olivo, G., Luzzaro, F., Docquier, J.-D. & Rossolini, G. M. (2013). FIM-1, a new acquired metallo-blactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob Agents Chemother 57, 410-416.
30. Rajan, S. & Saiman, L. (2002). Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect 17, 47-56.
31. Rosser, S. J. & Young, H. K. (1999). Identification and characterization of class 1 integrons in bacteria from an aquatic environment. J Antimicrob Chemother 44, 11-18.
32. Sambrook, J. & Russell, D. W. (2001). Molecular Cloning: a Laboratory Manual, 3rd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
33. Sevillano, E., Gallego, L. & García-Lobo, J. M. (2009). First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. Pathol Biol (Paris) 57, 493-495.
34. Silby, M. W., Winstanley, C., Godfrey, S. A. C., Levy, S. B. & Jackson, R. W. (2011). Pseudomonas genomes: diverse and adaptable. FEMS Microbiol Rev 35, 652-680.
35. Speijer, H., Savelkoul, P. H., Bonten, M. J., Stobberingh, E. E. & Tjhie, J. H. (1999). Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol 37, 3654-3661.
36. Talbot, G. H., Bradley, J., Edwards, J. E., Jr, Gilbert, D., Scheld, M., Bartlett, J. G. & Antimicrobial Availability Task Force of the Infectious Diseases Society of America (2006). Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42, 657-668.
37. Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., Quinn, J. P. & Colombian Nosocomial Resistance Study Group (2007). First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother 51, 1553-1555.
38. Walsh, T. R., Toleman, M. A., Poirel, L. & Nordmann, P. (2005). Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev 18, 306-325.
39. Watanabe, M., Iyobe, S., Inoue, M. & Mitsuhashi, S. (1991). Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 35, 147-151.
40. Wolter, D. J., Khalaf, N., Robledo, I. E., Vázquez, G. J., Santé, M. I., Aquino, E. E., Goering, R. V. & Hanson, N. D. (2009). Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases. Antimicrob Agents Chemother 53, 1660-1664.
41. Yatsuyanagi, J., Saito, S., Harata, S., Suzuki, N., Ito, Y., Amano, K. & Enomoto, K. (2004). Class 1 integron containing metallo-β-lactamase gene blaVIM-2 in Pseudomonas aeruginosa clinical strains isolated in Japan. Antimicrob Agents Chemother 48, 626-628.
42. Zhao, W. H. & Hu, Z. Q. (2011a). IMP-type metallo-β-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons. Crit Rev Microbiol 37, 214-226.
43. Zhao, W. H. & Hu, Z. Q. (2011b). Epidemiology and genetics of VIMtype metallo-β-lactamases in Gram-negative bacilli. Future Microbiol 6, 317-333.